| Financial Year |
March 31 2023 |
| Monetary Funds |
3,483,718,507.18 |
| Held-for-trading Financial Assets |
918,863,957.85 |
| Notes Receivable |
631,889,406.37 |
| Accounts Receivable |
247,081,161.22 |
| Advances to Suppliers |
148,006,094.73 |
| Other Receivables |
95,542,756.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,259,308,043.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
354,300,808.80 |
| Total Current Assets |
7,270,708,572.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
944,810,495.40 |
| Investment Properties |
158,155,545.57 |
| Fixed Assetes |
4,255,907,868.69 |
| Under-construction Projects |
1,009,272,016.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,185,918,934.64 |
| R&D expenses |
-- |
| Goodwill |
159,289,079.28 |
| Long-Term Deferred and Prepaid Expenses |
26,585,518.25 |
| Deferred Income Tax Assets |
232,271,551.72 |
| Other Non-Current Assets |
479,121,568.21 |
| Sub-Total of Non-Current Assets |
10,315,429,256.08 |
| Total Assets |
17,586,137,828.70 |
| Short-Term Loans |
1,549,036,049.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,797,314,977.16 |
| Accounts Payable |
888,306,536.02 |
| Accounts Received In Advance |
1,317,113.25 |
| Employee Compensation Payable |
17,535,981.40 |
| Taxes Payable |
224,179,581.03 |
| Interest Payable |
-- |
| Dividend Payable |
3,836,700.00 |
| Other payables |
350,489,664.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
214,630,862.13 |
| Other Current Liabilities |
41,264,268.83 |
| Sub-Total of Current Liabilities |
5,529,232,403.65 |
| Long-term Loans |
1,944,704,498.72 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
431,956,279.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
63,729,196.04 |
| Deferred Income Tax Liabilities |
109,932,917.50 |
| Other Non-Current Liabilities |
52,200,009.00 |
| Sub-Total of Non-Current Liabilities |
2,697,116,504.19 |
| Total Liabilities |
8,226,348,907.84 |
| Paid-In Capital(Or Share Stock) |
969,395,450.00 |
| Capital Surplus |
-930,182,064.99 |
| Surplus Reserve |
410,019,844.42 |
| LESS:Treasury Stock |
273,826,961.49 |
| Undistributed Profits |
8,312,188,875.52 |
| Minority Stockholder's Interest |
768,829,268.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,590,959,652.69 |
| Owner's Equity（Stockholder's Equity） |
9,359,788,920.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,586,137,828.70 |
